A human DAZ transgene confers partial rescue of the mouse Dazl null phenotype

Citation
R. Slee et al., A human DAZ transgene confers partial rescue of the mouse Dazl null phenotype, P NAS US, 96(14), 1999, pp. 8040-8045
Citations number
41
Categorie Soggetti
Multidisciplinary
Journal title
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
ISSN journal
00278424 → ACNP
Volume
96
Issue
14
Year of publication
1999
Pages
8040 - 8045
Database
ISI
SICI code
0027-8424(19990706)96:14<8040:AHDTCP>2.0.ZU;2-D
Abstract
In a subset of infertile men, a spectrum of spermatogenic defects ranging f rom a complete absence of germ cells (sertoli cell only) to oligozoospermia is associated with microdeletions, of the DAZ (deleted in azoospermia) gen e cluster on human distal Yq. DAZ encodes a testis-specific protein with RN A-binding potential recently derived from a single-copy gene DAZL1 (DAZ-lik e) on chromosome 3. Y chromosomal DAZ homologues are confined to humans and higher primates. It remains unclear which function unique to higher primat e spermatogenesis DAZ may serve, and the functional status of the gene rece ntly has been questioned. To assess the extent of functional conservation w e have tested the capacity of-a humanDAZ gene contained in a 225-kb yeast a rtificial chromosome to complement the sterile phenotype of the Dad null mo use (Dazl(-/-)), which is characterized by severe germ-cell depletion and m eiotic failure. Although Dazl(-/-) mice remained infertile when the DAZ tra nsgene was introduced, histological examination revealed a partial and vari able rescue of the mutant phenotype, manifest as a pronounced increase in t he germ cell population of the seminiferous tubules and survival to the pac hytene stage of meiosis. As well as constituting definitive proof of the sp ermatogenic role of the DAZ gene product, these findings confirm the high d egree of functional conservation between the DAZ and DAZL1 genes, suggestin g they may constitute a single target for contraceptive intervention and ra ising the possibility of therapeutic up-regulation of the DAZL1 gene in inf ertile men.